Pyxis Oncology
Quarterly Financials
| Values in thousands | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $11,038 |
Gross Profit | -459 | 11,470 | ||
EBITDA | -20,523 | -25,045 | -22,813 | -14,106 |
EBIT | -20,824 | -25,346 | -23,272 | -17,003 |
Net Income | -19,984 | -25,346 | -23,272 | -18,106 |
Net Change In Cash | 0 | 0 | 0 | 11,038 |
Free Cash Flow | -16,294 | -18,206 | -26,000 | -10,427 |
Cash | 3,856 | 18,855 | 7,238 | 15,422 |
Basic Shares | 83,508 | 63,991 | 63,469 | 62,143 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $13,858 | $16,146 | $0 | $0 |
Gross Profit | 11,470 | 15,671 | -2,000 | -1,836 |
EBITDA | -73,724 | -65,514 | -71,863 | -122,772 |
EBIT | -78,235 | -68,496 | -73,790 | -123,481 |
Net Income | -79,621 | -77,331 | -73,790 | -117,953 |
Net Change In Cash | 13,858 | 16,146 | 0 | 0 |
Cost of Revenue | -95,551 | |||
Free Cash Flow | -63,511 | -57,909 | -77,435 | -95,734 |
Cash | 15,422 | 19,473 | 9,664 | 179,293 |
Basic Shares | 62,143 | 58,445 | 39,904 | 33,033 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-09-30 | -$0.24 |
2026-06-30 | -$0.40 |
2026-03-31 | -$0.37 |
2025-12-31 | -$0.29 |